What the name refers to
A dopamine D2 receptor agonist authorised for hyperprolactinaemic disorders in many markets.
Evidence and regulatory context
At least one regulated medicine or indication exists for this active ingredient. Authorisation is tied to a particular formulation, manufacturer, indication and jurisdiction; it does not validate unrelated products using the same name.
Reading product records
Most names in this group refer to prescription medicines with indication-specific evidence and contraindications. Product records should prioritise licensed packaging, pharmacy provenance, batch traceability and the exact active ingredient instead of relying on seller claims.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.